Abstract:Remdesivir was the first antiviral agent to receive FDA authorization
for severe COVID-19 management, which restricts its use with severe
renal impairment due to concerns that active metabolites might
accumulate, causing renal toxicities. With limited treatment options,
available evidence on such patient groups is important to assess for
future safety.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.